News
First customer boards Recipharm’s soft mist inhaler technology platform
Resyca, Recipharmโs joint venture with Medspray, has boarded its first pharmaceutical customer on the soft mist inhaler (SMI) platform. An agreement has been signed involving milestones and royalties for exclusivity on the specific drug product.
The innovative SMI platform consists...
News
Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced a strategic investment in Nirrin Technologies, a provider of next generation sensors and analytics for real-time, in-process monitoring and analysis in upstream and downstream bioprocessing...
News
Inogen enhances commercial capabilities through partnership with Ashfield
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced a breakthrough agreement to enhance its go-to-market capabilities through a strategic partnership with Ashfield, part of UDG Healthcare.
The partnership will support...
News
Gene Therapy Origin Story: It’s Science, Not Fiction
For thousands of years humans have developed the genetic structure of plants and animals through selection and controlled breeding to enhance certain characteristics. This started as trial and error with no real understanding of what or why this happened....
News
mRNA Vaccines: History
Introduction
Vaccines protect hundreds of millions of people every year from a host of diseases that have the potential to take millions of lives. When administered to enough of the population they can even eradicate the disease altogether. For example,...
Drug Research
InSilicoTrials and Galileo Research announce their partnership
Innovation and cutting-edge technology to reduce Research and Development time and costs: InSilicoTrials, a company with broad expertise in Computational Modeling and Simulation, IT and cloud solutions for the healthcare sector, and Galileo Research established a partnership to apply...
Drug Research
Velocity Clinical Research’s multi-site acquisitions signal new frontier for clinical site management industry
Velocity Clinical Research announces it has acquired two multi-site companies, VitaLink Research and the National Research Institute, for an undisclosed amount. The double acquisition adds 11 sites to Velocityโs existing 18, making it the largest fully integrated site management...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















